Birth Control and Testosterone: Why Your Total Reads Normal and Your Free Does Not

The pill raises SHBG, the protein that binds testosterone, hard enough that your total testosterone can read perfectly normal while the fraction your cells can actually use collapses. Two women, identical labs, completely different free hormone levels.

Okay so, imagine two women. Same age bracket, 43 years old. Same complaint: exhausted, zero libido, flat mood, can't build muscle no matter how hard they train. Their doctors run testosterone panels. Both come back "normal." One gets told she's just stressed. The other gets told she's just entering perimenopause.

One of those women is severely testosterone deficient. The other isn't.

And you'd never know it from their labs, unless you knew exactly what to look for.

Both women are real, documented cases from published research (PMC7663738, open access). Woman A: total testosterone 50.4 ng/dL, SHBG 28 nmol/L. Woman B: total testosterone 48.9 ng/dL, SHBG 196 nmol/L, nearly 7 times higher. Their total testosterone is nearly identical. But Woman B's free testosterone, the fraction that actually enters cells and does anything, is 4.4 times lower. She is functionally testosterone deficient while her labs say "normal."

The difference? Woman B was on the pill.

What SHBG Is, and Why It's Rarely Measured

Sex Hormone-Binding Globulin, SHBG, is a protein your liver produces that acts like a taxi service for hormones. It picks up testosterone (and estrogen) and carries them through your bloodstream. The problem is, hormones riding in the taxi can't get out and do their job. Only free testosterone, the fraction not bound to SHBG or albumin, can enter your cells, activate receptors, and produce effects.

Total testosterone is how much money is in your bank account. Free testosterone is how much cash you actually have in your wallet. SHBG is what moved everything from your wallet to a locked vault that requires three signatures to open.

When SHBG goes up, free testosterone goes down, and the drop is disproportionately large. SHBG binds testosterone with much higher affinity than it binds estrogen. A modest increase in SHBG can slash free testosterone by 40 to 60%. A large increase, the kind triggered by oral contraceptive pills, can render a woman's free testosterone clinically undetectable while her total testosterone reads perfectly fine.

Standard lab panels check total testosterone. Almost no routine perimenopausal workup checks SHBG. This is the diagnostic blindspot that's leaving a generation of women undiagnosed.

How the Pill Does This

Combined oral contraceptive pills (OCPs) contain two hormones: a synthetic estrogen, almost always ethinyl estradiol, and a progestin. The ethinyl estradiol is the mechanism here. It sends a powerful signal to your liver: produce more SHBG.

And the liver listens.

In meta-analysis, the average increase is around 99 nmol/L, causing roughly a 61% drop in free testosterone (Zimmerman 2013). For reference, a normal SHBG in a premenopausal woman not on the pill is somewhere around 20 to 60 nmol/L. OCP users routinely run 100 to 200 nmol/L. That is a systemic reconfiguration of how much testosterone reaches her cells.

Now add the progestin variable, because not all pills are equally bad here.

Levonorgestrel-containing pills (many older and generic formulations) are androgenic, meaning the progestin itself has mild testosterone-like activity at androgen receptors. This partially counteracts the SHBG rise from ethinyl estradiol, capping the increase around 50%. Still elevated, but not catastrophic.

Drospirenone-containing pills, Yaz, Yasmin, Beyaz, and their generics, are a different story. Drospirenone is derived from spironolactone, which is an anti-androgen. It fails to counteract the SHBG rise, and it also blocks testosterone at the receptor level. So you get maximum SHBG elevation from the ethinyl estradiol and direct anti-androgenic activity from the progestin. Double suppression.

Desogestrel- and gestodene-containing pills (third-generation formulations common in Europe) cause SHBG increases of 200 to 300% above baseline. That is not a typo.

If you want the cleanest demonstration of this, it's a randomized trial from 2022. Researchers assigned healthy women to one of three arms for nine weeks: a pill with ethinyl estradiol, a pill using estradiol valerate (a natural estrogen) instead, or the progestin alone. In the ethinyl estradiol group, SHBG rose 385% and the free androgen index fell 72%.

Their total testosterone didn't fall at all.

Read that again, because it's the whole problem in one result. The number your doctor ordered stayed completely normal while the testosterone their cells could actually use dropped by nearly three quarters. The estradiol valerate arm raised SHBG by only 56%, and the progestin alone changed nothing. So the synthetic estrogen is the culprit, and not every pill does this to the same degree.

What Happens When You Stop (I Had This Wrong)

An earlier version of this article told you that SHBG stays elevated for six months or more after you quit, and that your liver takes a year or longer to reset after years of synthetic estrogen. I based that on a retrospective study from 2006. Better evidence has been published since, and it doesn't support what I wrote. So here's the correction, and it's good news.

A 2024 study in Blood did what the older one couldn't. It enrolled women before they stopped, so each woman served as her own baseline, then measured SHBG at one, two, four, six and twelve weeks after cessation. It also included a comparison group of women who weren't on hormonal contraception at all.

SHBG came down fast. It fell from 167 nmol/L to 55.4. About three quarters of that entire decline happened in the first two weeks, and close to 90% of it within four. By twelve weeks, the women who had stopped were statistically indistinguishable from the women who had never used the pill.

The older study's design explains the difference. It was a retrospective chart review, comparing separate groups of women rather than following the same women over time, and its participants were recruited from a sexual dysfunction clinic. That's a group selected precisely because their symptoms hadn't resolved. If you want to find women who didn't normalize, recruiting from a clinic full of women who still feel terrible is how you'd do it.

I'd rather correct this in public than leave it standing, partly because it's the honest thing and partly because the corrected version is more useful to you. If quitting the pill fixed this in two weeks, that's a much better piece of information than "brace yourself for a year."

It also sharpens the diagnostic question, which I'll come back to at the end.

The Perimenopause Timing Trap

Now here's where this becomes a generation-level problem.

Women's testosterone declines continuously from the mid-20s, roughly half by age 40 (the full physiology is in My brain went from black and white to technicolor), before most women have a single hot flash or missed period. The slope runs the length of the reproductive lifespan, and menopause falls partway down it.

Plenty of women don't stop the pill at 35. They stay on it into their mid and late 40s, often right up to menopause, because it's handling contraception and heavy bleeding and nobody suggested otherwise.

That means two things are happening in the same body at the same time:

Her natural testosterone is already down to roughly half of what it was at 25, purely from age.
The ethinyl estradiol is driving SHBG several-fold higher, binding up a large fraction of what's left.

Her free testosterone can be scraping the floor while her total testosterone reads "technically normal." And the symptoms of that, low libido, fatigue, brain fog, flat mood, no motivation, no muscle gain no matter how hard she trains, are indistinguishable from perimenopause itself.

So she gets told: "You're in perimenopause. This is normal."

Which is true, and completely misleading, and worse, it's actionable in a way nobody tells her. The pill, unlike perimenopause, is something she can stop taking.

The Diagnosis Being Missed in Millions of Exams

A perimenopausal woman presents with classic low testosterone symptoms. Her doctor runs a testosterone panel. "Total testosterone: 42 ng/dL, normal range for women." She's told her testosterone is fine.

Nobody runs SHBG. Nobody runs free testosterone. The total testosterone number is real, technically accurate, and essentially useless for understanding whether she has sufficient bioavailable testosterone.

The correct workup: total testosterone + free testosterone by equilibrium dialysis + SHBG. Equilibrium dialysis is the gold standard for measuring free testosterone. Other methods (calculated free T, direct immunoassay) introduce substantial error at the low concentrations found in women. Order all three. Draw in the morning when testosterone peaks.

Most primary care doctors don't order this panel. Many OB/GYNs don't either, unless they've specifically trained in menopause medicine. Women who find answers are typically the ones who've done enough reading to walk in and ask for it by name, and then find a provider who won't dismiss the request.

What to Do If This Is You

If you're currently on a combined oral contraceptive and you're anywhere near your 40s, this is worth a conversation with your prescriber. Here's what to ask:

The lab request: "Can we run a complete hormonal panel including total testosterone, free testosterone by equilibrium dialysis, and SHBG? I've read that OCP use can suppress free testosterone through SHBG elevation and I'd like a full picture."

If you're still on OCPs and still need contraception: Not all options raise SHBG equivalently. The Mirena IUD (levonorgestrel-containing, local delivery) does not significantly elevate SHBG. Progestin-only pills have a smaller SHBG effect than combined pills. These are conversations worth having.

If you stop the pill, give it a month, then judge. SHBG normalizes fast, so a month off is enough for the pill's contribution to have largely cleared. This gives you a genuinely useful test. If you feel noticeably better within four to six weeks, SHBG suppression was a real part of what was wrong with you. If you're three months out and still flat, the pill is no longer the explanation, and pushing on that theory will waste your time. Look at thyroid, ferritin, sleep, and perimenopause itself instead. Either answer is worth having.

If free testosterone comes back low relative to SHBG: The treatment conversation is nuanced, low-dose testosterone therapy for women is supported by NAMS and ISSSWSH clinical guidelines for hypoactive sexual desire disorder, though guidelines for broader symptoms are still evolving. Find a menopause specialist or a provider trained through NAMS or ISSWSH for this conversation, not a general practitioner who's never ordered free T for a woman.

What This Is Costing Women

How many women are right now walking through their lives carrying the hormonal signature of severe testosterone deficiency, zero drive, zero desire, can't build muscle, brain in a fog, while their labs read "normal total testosterone" and their doctor reassures them that everything is fine?

We make women feel crazy for noticing. We hand them antidepressants. We tell them it's stress, or menopause, or just getting older.

Some of it is perimenopause. Some of it is stress. And some of it is that a medication millions of women take faithfully, for years, quietly reconfigures their liver's hormone-binding protein production, and no one ever mentioned that this could happen, or that there was a test that could detect it.

The test takes 10 minutes to order. The information changes what a woman asks for and what her doctor looks for.

Ask for the full panel: total testosterone, free testosterone by equilibrium dialysis, SHBG. Those three numbers together tell a story that one number alone never will.

Sources: - Haverinen A et al. (2022). Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis. J Clin Endocrinol Metab, 107(7):e3008 to e3017. DOI. Randomized trial. Ethinylestradiol raised SHBG 385% and cut the free androgen index 72% while total testosterone was unchanged. - Hugon-Rodin J et al. (2024). Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives. Blood, 143(1):70 to 78. DOI. Prospective. SHBG fell from 167 to 55.4 nmol/L, about 76% of it within two weeks, and matched never-users by 12 weeks. - Zimmerman Y et al. (2013). The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Human Reproduction Update, 20(1):76 to 105. - ISSSWSH Clinical Practice Guideline for Systemic Testosterone for HSDD in Women. PMC - NAMS Practice Pearl, Testosterone Use for Hypoactive Sexual Desire Disorder. NAMS/Huntington Health - Choosing a combined oral contraceptive pill. PMC

Annette Thompson is 57, the founder of adoption.com, and a menopause advocate writing about evidence-based women's health.